SciELO - Scientific Electronic Library Online

 
vol.36 número2Presencia de anticuerpos sericos contra Neospora caninum en equinos en Chile índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Archivos de medicina veterinaria

versión impresa ISSN 0301-732X

Arch. med. vet. v.36 n.2 Valdivia dic. 2004

http://dx.doi.org/10.4067/S0301-732X2004000200012 

Revista Arch. Med. Vet., Vol. XXXVI Nº 2, julio 2004, p. 207-210

COMUNICACIONES

 

In vitro susceptibility of Arcobacter butzleri to six antimicrobial drugs*

Susceptibilidad in vitro de Arcobacter butzleri a seis drogas antimicrobianas

 

L. Otth, T.M., M. Wilson, T.M., R. Cancino, T.M., H. Fernández1, T.M., D. SC.

Instituto de Microbiología Clínica, Universidad Austral de Chile, PO BOX 567. Valdivia. Chile.
* Financial Support: Grant FONDECYT 1030245.


Resumen

Se determinaron los patrones de susceptibilidad de 50 cepas de A. butzleri mediante el método del E-test. Ninguna cepa fue resistente a gentamicina y tetraciclina, pero, hubo cepas resistentes a eritromicina (2%) y ciprofloxacina (2%). Además, el 90 y el 98% de las cepas fueron resistentes a ampicilina y cloramfenicol respectivamente. Solamente dos de las 45 cepas ampicilina-resistentes fueron productoras de ß-lactamasa. Palabras clave: Arcobacter butzleri, susceptibilidad antimicrobiana, bacterias emergentes, E-test, ß-lactamasa

Palabras Claves: Arcobacter butzleri, susceptibilidad antimicrobiana, bacterias emergentes, E-test, ß-lactamasa.


Summary

The susceptibility patterns of 50 A. butzleri strains to six antimicrobial agents were determined using the E-test method. No strain was found to be resistant to gentamicin and tetracycline, but two different strains (2%) were resistant to erythromycin and ciprofloxacin. Ninety and 98% of the strains were resistant to ampicillin and chloramphenicol, respectively. Only two of the 45 ampicillin resistant strains were able to produce ß-lactamase.

Key Words: Arcobacter butzleri, antibiotic susceptibility, emerging bacteria, E-test, ß-lactamase.


 

INTRODUCTION

The genus Arcobacter belongs to the family Campylobacteraceae, class Proteobacteria, subclass Gracillicutes and comprises four species Arcobacter butzleri, A. cryaerophilus, A. nitrofigilis and A. skirrowii, formerly known as aerotolerant Campylobacter-like organisms (Vandamme, 2000).

The first isolates were obtained by Ellis et al. (1977) from aborted bovine fetuses. Further studies related these microorganisms with mastitis and abortion in the bovine, ovine, equine and porcine species (Logan et al., 1982; Vandamme 2000).

Of the four described species, only A. cryaerophilus and A. butzleri have been isolated from human beings, and are associated with bacteremia and diarrhea. A. butzleri has been isolated from patients with endocarditis, peritonitis and appendicitis. Both are considered as emerging foodborne pathogens that could be acquired by consuming mussels, poultry meat, offal and contaminated water (Jacob et al., 1998, Mansfield and Forsythe, 2000).

Some studies have been carried out in industrialized countries in order to establish the susceptibility of Arcobacter to several antimicrobial drugs. As the antibiotic resistance of Arcobacter strains from developing countries is not known, the aim of this study was to assess the susceptibility and resistance patterns of A. butzleri strains isolated in Southern Chile.

MATERIAL AND METHODS

A total of 50 strains of A. butzleri isolated from cattle (5), pelicans (8) duck feces (2) mussels (17), chicken livers for human consumption (8) and river water (10) were examined. All the strains were isolated using the enrichment medium of de Boer et al. (1996), incubated aerobically at 26ºC for 48 h. They were then plated on the medium of Atabay and Corry (1998) and incubated as described above. All the strains were identified phenotypically using the standard tests (Vandamme, 2000) complemented with the APICAMPY system (bioMêrieux).

Susceptibility to ampicillin, ciprofloxacin, chloramphenicol, erythromycin, gentamicin and tetracycline was assessed using the E-test method (AB Biodisk, Solna, Sweden). This method has been used previously in our laboratory for testing Campylobacter jejuni (Fernández et al., 2000). In brief, several colonies of each strain, obtained from a fresh culture on a blood agar plate, were suspended in 5 ml of Mueller-Hinton broth to a turbidity equal to 0.5 MacFarland standard. The suspensions were inoculated with sterile swabs onto 150 mm diameter Mueller-Hinton agar plates supplemented with 5% sheep blood. The agar surfaces were allowed to dry, and six E-test strips were applied to each plate. Plates were incubated aerobically at 26ºC for 48 h and inhibitory concentrations were read at the point where the elliptical zone of inhibition intersected the E-test strip. Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922 and a C. jejuni isolate of known susceptibility/resistance were used as control strains. The susceptibility criteria were those defined for C. jejuni by the National Committee for Clinical Laboratory Standards (National Committee for Clinical Laboratory Standards, 2003).

RESULTS AND DISCUSSION

All the ampicillin-resistant strains (45) were tested for ß-lactamase using the chromogenic cephalosporin method (DIFCO Laboratories) complemented with a disc diffusion test for detecting ampicillin-sulbactam susceptibility.

The results of the E-test are shown in table 1 and are expressed as the Minimal Inhibitory Concentrations 50 and 90 (MIC50 and MIC90), corresponding to the antibiotic concentration that inhibits at least the 50 or 90% of the strains respectively.

All the strains were susceptible to gentamicin and tetracycline. The lowest MIC50 and MIC90 values were obtained with gentamicin and ciprofloxacin. The latter, together with erythromycin, showed the lowest percentages of resistance (2%). The highest MIC50 and MIC90 values were obtained with ampicillin and chloramphenicol which also showed high percentages of resistance (90 and 98% respectively).

 

TABLE 1

MIC50, MIC90 and percentages of resistance obtained for 50 strains of A. butzleri.
MIC50, MIC90 y porcentajes de resistencia obtenidos en 50 cepas de A. butzleri.
 
Antibiotics
Range
(mcg/ml)
MIC50
MIC90
 %
Resistance
 Gentamicin
Tetracycline
Erythromycin
Ciprofloxacin
Ampicillin
Chloramphenicol
 0.064-0.5
0.5-8
0.25-8
0.012-3
1-256
3-256
 0.125
2
1.5
0.023
24
64
 0.38
4
3
0.094
64
192
 0
0
2
2
90
98

 

All the strains were susceptible to gentamicin and tetracycline. With regard to erythromycin and ciprofloxacin we found that 98% of the strains were susceptible to both antibiotics with one strain resistant to erythromycin and another to ciprofloxacin. These results are similar to those reported by Atabay and Aydin (2001). They found that all 39 strains of A. butzleri studied by the disk diffusion method were susceptible to tetracycline, to the aminoglycoside tobramicin and to the quinolones danofloxacin and enrofloxacin. Harrass et al. (1998) reported that two out of 89 A. butzleri strains were resistant to tetracycline and another two showed intermediate resistance to erythromycin, also using the disc diffusion method. Kiehlbauch et al. (1992), using the broth microdilution method, found that aminoglycosides, quinolones and tetracyclines were most active in vitro against 64 strains of C. butzleri (currently A. butzleri).

The other two antibiotics included in our study were ampicillin and chloramphenicol with five strains susceptible to the former and only one to the latter. These results are in agreement with those reported by other authors for ampicillin (Kiehchelbauch et al., 1992; Harrass et al., 1998; Atabay and Aydin, 2001). However, some differences have been observed with relation to chloramphenicol. While Kiehlbauch et al. (1992) reported 100% resistance, Harrass et al. (1998) found 11.2% of strains to be resistant, but all the strains studied by Atabay and Aydin (2001) were susceptible to this antibiotic. Such differences could be due to local differences, probably related to the use of this antibiotic. In Chile, chloramphenicol is the drug of choice in the treatment of typhoid fever which, declining in incidence, remains endemic here (Fica et al., 2001).

All the ampicillin resistant strains of A. butzleri (45) were tested for beta lactamase production. Table 2 shows the results obtained with the chromogenic cepahlosporin test and the disc diffusion susceptibility test for ampicillinsulbactam. Only two strains were able to produce ß-lactamase, giving a positive chromogenic cepaholosporin test. However, because the use of this test to determine beta lactamase production in species of the genus Arcobacter has not been described before, we repeated these tests with a disc diffusion test, using ampicillin and ampicillin-sulbactam discs. Both strains were resistant to ampicillin but susceptible to the combination ampicillin-sulbactam. As sulbactam is a beta lactamase inhibitor we conclude that in these two strains the ampicillin resistance mechanism could be mediated by beta lactamase production.

 

TABLE 2

ß-Lactamase production and susceptibility to ampicillin-sulbactam in 45 A. butzleri ampicillin resistant strains.
Producción de ß-lactamasa y susceptibilidad a ampicilinasulbactam en 45 cepas de A. butzleri ampicilina resistentes.
 
Characteristic
n/N
%
ß-lactamase +
ß-lactamase –
Susceptible to ampicillin-sulbactam
Resistant to ampicillin-sulbactam
2/45
43/45
2/45
43/45
4.5
95.5
4.5
95.5
 
N: number of positive strains; n: number of ampicillin resistant strains.

 

Finally, we conclude that, in general, our strains are susceptible to gentamicin, tetracycline, erythromycin and ciprofloxacin. They have high resistance to ampicillin and chloramphenicol. Further studies should be conducted in order to establish the resistance mechanisms in A. butzleri as well as to explain the geographical differences observed in their susceptibility to these antimicrobial drugs.

REFERENCES

ATABAY, I., J. CORRY. 1998. Evaluation of a new Arcobacter enrichment medium and comparison with two media developed for enrichment of Campylobacter spp. Int. J. Food. Microbiol. 41: 53-58.         [ Links ]

ATABAY, H.I., F. AYDIN. 2001. Susceptibility of Arcobacter butzleri isolates to 23 antimicrobial agents. Lett. Appl. Microbiol. 33:430-433.        [ Links ]

DE BOER, E., J.J. TILBURG, D.L. WOODWARD, H. LIOR, W.M. JOHNSON. 1996. A selective medium for the isolation of Arcobacter from meats. Lett. Appl. Microbiol. 23: 64-66.         [ Links ]

ELLIS, W.A., S.D. NELLY, J.J. O’BRIEN, H.W. FERGUSON, J. HANNA. 1977. Isolation of Spirillum/ Vibrio-like organisms from bovine fetuses. Vet. Rec. 100: 451-452.        [ Links ]

FERNANDEZ, H., M. MANSILLA, V. GONZALEZ. 2000. Antimicrobial Susceptibility of Campylobacter jejuni subsp. jejuni assessed by E-test and double dilution agar method in Southern Chile. Mem. Inst. Oswaldo Cruz 95: 247-249.         [ Links ]

FICA, A., M. ALEXANDRE, S. PRAT, A. FERNANDEZ, J. FERNANDEZ, I. HEITMANN. 2001. Cambios epidemiológicos de las salmonelosis en Chile: desde Salmonella tiphy a Salmonella enteritidis. Rev. Chil. Infectol. 18: 85-93.         [ Links ]

HARRASS, B., S. SCHWARZ, S. WENZEL. 1998. Identification and characterization of Arcobacter isolates from broilers by biochemical tests, antimicrobial resistance patterns and plasmid analysis. Zbl. Vet. Med (B) 45: 87-94.         [ Links ]

JACOB, J., D. WOODWARD, I. FEUERPFEIL, W.M. JOHNSON. 1998. Isolation of Arcobacter butzleri in raw water and drinking water treatment plants in Germany. Zbl. Hyg. Umweltmed. 201: 189-198.         [ Links ]

KIEHLBAUCH, J.A., C.N. BAKER, I.K. WACHSMUTH. 1992. In vitro susceptibilities of aerotolerant Campylobacter isolates to 22 antimicrobial agents. Antimicrob. Agents Chemother. 36: 717-722.         [ Links ]

LOGAN, E.F., S.D. NEIL, D.P. MACKIE. 1982. Mastitis in dairy cows associated with an aerotolerant Campylobacter. Vet. Rec. 110: 229-230.         [ Links ]

MANSFIELD, L.P., S.J. FORSYTHE. 2000. Arcobacter butzleri, A. skirrowii and A. cryaerophilus – Potential emerging human pathogens. Rev. Med. Microbiol. 11: 161-170.         [ Links ]

NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS (NCCLS). 2003. Performance standards for antimicrobial disk susceptibility tests. NCCLS document M100-S13 Villanova, PA.        [ Links ]

VANDAMME, P. Taxonomy of the Family Campylobacteraceae. 2000. IN: Nachamkin, I., Blaser, M.J. (Eds) Campylobacter 2nd Edition, ASM Press, Washington, pp. 3-26.        [ Links ]

 

Aceptado: 17.08.2004